SEC FORM 4/A

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MOORE JOHN A

(Last)

(First)

(Middle)

C/O EDSON MOORE HEALTHCAREVENTURES, INC

101 BROOKMEADOW ROAD

(Street)

WILMINGTON

19807

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ELITE PHARMACEUTICALS INC /DE/ [ ELI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2004

4. If Amendment, Date of Original Filed (Month/Day/Year)
12/12/2002

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/04/2003⁽¹⁾		P		50,000	A	$2	814,218	I	By Edson Moore Healthcare Ventures, Inc., a Delaware corporation ("EMC")

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrant	$18	10/17/2000		A		100,000		10/17/2000	10/17/2005	Common Stock	100,000	⁽⁶⁾	100,000	I	By EMC
Options	$2.34	06/22/2004		A		30,000		06/22/2004	⁽²⁾	Common Stock	30,000	⁽⁷⁾	360,000	D
Options	$2.21⁽³⁾	01/31/2003		A		30,000		⁽⁴⁾	⁽³⁾	Common Stock	30,000	⁽⁷⁾	360,000	D
Options	$2.01	06/13/2003		A		300,000		06/13/2003	⁽⁵⁾	Common Stock	300,000	⁽⁷⁾	360,000	D

Explanation of Responses:

1. 814,218 shares of Common Stock are beneficially owned by EMC, of which Mr. Moore is the president and a principal stockholder of EMC, including 50,000 shares of Common Stock acquired December 4, 2003 pursuant to a private placement, which acquisition was approved by the stockholders of the Issuer on June 22, 2004.

2. Options expire on the earlier of (i) June 22, 2014 and (ii) the date that is two years after the Reporting Person ceases to be a director of or a consultant or advisor to the Issuer.

3. On June 22, 2004 the stockholders of the Issuer ratified the prior reduction of the exercise price of the options from $6.50 to $2.21 per share and the amendment of the expiration date of the options as follows: Options expire on the earlier of (i) January 13, 2013 and (ii) the date that is two years after the Reporting Person ceases to be a director of or a consultant or advisor to the Issuer.

4. Options vest as follows: (i) 10,000 shares on December 1, 2003, (ii) 10,000 shares on December 1, 2004 and (iii) 10,000 shares on December 1, 2005.

5. On June 22, 2004 the stockholders of the Issuer ratified the prior amendment of the expiration date to be as follows: Options expire on the earlier of (i) June 13, 2013, and (ii) the date that is two years after the Reporting Person ceases to be a director of or a consultant or advisor to the Issuer.

6. Part of a package of securities purchased September 27, 2002 for $485,000.

7. Granted by the Issuer.

	/s/ John A. Moore	06/23/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.